The first published randomised controlled trial of laser treatment for vaginal atrophy raises serious questions

Melissa Buttini, Melissa J Buttini, Christopher Maher
The Medical journal of Australia · 2018 · vol. 209(9) , pp. 376–377 · doi:10.5694/mja18.00187 · PMID:30376654 · W2898750018
Other OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-12 ⓘ

The first published randomized controlled trial of laser treatment for vaginal atrophy raises serious questions regarding the efficacy or safety of this intervention.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Estrogens Laser Therapy Vagina Administration, Intravaginal Atrophy Atrophy Estrogens Female Humans Laser Therapy Postmenopause Randomized Controlled Trials as Topic Research Design Vagina

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (11)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:23:18.497579+00:00
License: CC0 · commercial use OK